Collateral benefits on other respiratory infections during fighting COVID-19.
Med Clin (Barc)
; 155(6): 249-253, 2020 09 25.
Article
en En, Es
| MEDLINE
| ID: mdl-32586667
ABSTRACT
PURPOSE:
Influenza virus infection is associated with a high disease burden. COVID-19 caused by SARS-CoV-2 has become a pandemic outbreak since January 2020. Taiwan has effectively contained COVID-19 community transmission. We aimed to validate whether fighting COVID-19 could help to control other respiratory infections in Taiwan.METHOD:
We collected week-case data of severe influenza, invasive Streptococcus pneumoniae disease and death toll from pneumonia among 25 calendar weeks of the influenza season for four years (2016-2020), which were reported to Taiwan CDC. Trend and slope differences between years were compared.RESULT:
A downturn trend of severe influenza, invasive S. pneumoniae disease and the death toll from pneumonia per week in 2019/2020 season and significant trend difference in comparison to previous seasons were noted, especially after initiation of several disease prevention measures to fight potential COVID-19 outbreak in Taiwan.CONCLUSIONS:
Fighting COVID-19 achieved collateral benefits on significant reductions of severe influenza burden, invasive S. pneumoniae disease activity, and the death toll from pneumonia reported to CDC in Taiwan.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Infecciones Neumocócicas
/
Neumonía Viral
/
Infecciones por Coronavirus
/
Gripe Humana
/
Pandemias
/
Betacoronavirus
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Límite:
Humans
País como asunto:
Asia
Idioma:
En
/
Es
Año:
2020
Tipo del documento:
Article